Cancer-Associated Ischemic Stroke Mechanisms

Cancer-associated ischaemic stroke arises from a complex interplay between tumour biology and the haemostatic system. Malignancies can provoke a hypercoagulable state through release of procoagulant factors such as tissue factor and mucin, as well as through the shedding of extracellular vesicles carrying active clotting molecules. Inflammation and neutrophil extracellular trap formation further amplify thrombus formation. Some tumours invade vascular structures directly or compress vessels, while others promote endothelial dysfunction and platelet activation. These processes often manifest as multifocal cerebral infarcts detectable by diffusion-weighted imaging, and correlate with elevated biomarkers such as D-dimer. In many patients, stroke may be the first indication of occult cancer, underscoring the need for heightened clinical vigilance.

Research from Nature Portfolio

Recent studies have quantified the long-term risk of fatal stroke in cancer survivors, demonstrating that overall mortality from cerebrovascular events among patients with prostate, breast and colorectal cancers is more than double that of the general population. Those with brain or gastrointestinal tumours exhibit the highest standardised mortality ratios, which remain elevated decades after diagnosis. The temporal pattern indicates a progressive rise in stroke risk as cancer survivors age, emphasising the need for ongoing surveillance and tailored secondary prevention strategies.

Cancer-Associated Ischemic Stroke Mechanisms publication trend

The graph below shows the total number of articles in cancer-associated ischemic stroke mechanisms across all publications each year (not limited to Nature Index journals).

Technical terms

Ischaemic stroke: Vessel occlusion leading to brain tissue infarction.

Hypercoagulability: Enhanced tendency for blood clot formation induced by cancer-related factors.

Extracellular vesicles: Tumour cell–derived particles that carry procoagulant and inflammatory molecules.

Trousseau syndrome: Recurrent thrombosis linked to malignancy, often migratory in nature.

D-dimer: A fibrin degradation product elevated in active clot formation and breakdown.

Diffusion-weighted imaging: MRI technique sensitive to early changes in water diffusion in acute infarcts.

References

1. Association of Stroke at Young Age With New Cancer in the Years After Stroke Among Patients in the Netherlands. JAMA Network Open (2023).
2. Stroke among cancer patients. Nature Communications (2019).
3. Clues to Occult Cancer in Patients with Ischemic Stroke. PLOS ONE (2012).
4. Three-Territory DWI Acute Infarcts: Diagnostic Value in Cancer-Associated Hypercoagulation Stroke (Trousseau Syndrome). American Journal of Neuroradiology (2016).
5. Cancer Cell-Derived Extracellular Vesicles Are Associated with Coagulopathy Causing Ischemic Stroke via Tissue Factor-Independent Way: The OASIS-CANCER Study. PLOS ONE (2016).
6. Effectiveness of mechanical thrombectomy in cancer-related stroke and associated factors with unfavorable outcome. BMC Neurology (2021).